î
î
Apimeds Pharmaceuticals US Inc
APUS1.570USD
-0.170-9.77%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
12.41Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ
å ± Apimeds Pharmaceuticals US Inc äŒæ¥å
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
äŒæ¥æ
å ±î
äŒæ¥ã³ãŒãAPUS
äŒç€ŸåApimeds Pharmaceuticals US Inc
äžå Žæ¥May 09, 2025
æé«çµå¶è²¬ä»»è
ãCEOãMr. Erik C. Emerson
åŸæ¥å¡æ°2
蚌åžçš®é¡Ordinary Share
決ç®ææ«May 09
æ¬ç€Ÿæåšå°100 Matawan Road
éœåžMATAWAN
蚌åžååŒæNYSE American Consolidated
åœUnited States of America
éµäŸ¿çªå·07747
é»è©±çªå·18482015010
ãŠã§ããµã€ãhttps://www.apimedsus.com/
äŒæ¥ã³ãŒãAPUS
äžå Žæ¥May 09, 2025
æé«çµå¶è²¬ä»»è
ãCEOãMr. Erik C. Emerson
圹å¡äžèŠ§î
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Dr. Hankil Yoon, Ph.D.
Dr. Hankil Yoon, Ph.D.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Erik C. Emerson
Mr. Erik C. Emerson
Chief Executive Officer, Director
Chief Executive Officer, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
643.88K
+4.63%
Dr. Christopher Kim, M.D.
Dr. Christopher Kim, M.D.
Chairman of the Board, Chief Medical Officer
Chairman of the Board, Chief Medical Officer
277.50K
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
åçå
èš³
ããŒã¿ãªã
ããŒã¿ãªã
äºæ¥å¥
å°åå¥
ããŒã¿ãªã
æ ªäž»
æŽæ°æå»: Wed, Jul 2
æŽæ°æå»: Wed, Jul 2
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Apimeds, Inc.
37.90%
Inscobee, Inc.
17.52%
Dominus IB, Inc
6.91%
Emerson (Erik C)
6.48%
Koo (Jakap)
5.56%
Other
25.62%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Apimeds, Inc.
37.90%
Inscobee, Inc.
17.52%
Dominus IB, Inc
6.91%
Emerson (Erik C)
6.48%
Koo (Jakap)
5.56%
Other
25.62%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
67.52%
Individual Investor
14.44%
Other
18.04%
æ©é¢æè³å®¶ä¿ææ ªî
æŽæ°æå»: Wed, Jul 2
æŽæ°æå»: Wed, Jul 2
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
7
9.49M
81.96%
+7.39M
2025Q2
7
9.49M
81.96%
+7.39M
2025Q1
2
2.10M
18.15%
+2.10M
æ ªäž»ååî
äŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Apimeds, Inc.
4.39M
37.9%
+4.39M
--
May 12, 2025
Inscobee, Inc.
2.03M
17.52%
+544.04K
+36.65%
May 12, 2025
Dominus IB, Inc
800.00K
6.91%
+800.00K
--
May 09, 2025
Emerson (Erik C)
750.00K
6.48%
+750.00K
--
May 16, 2025
Koo (Jakap)
643.88K
5.56%
+28.50K
+4.63%
May 12, 2025
Seed 1 ho
600.00K
5.18%
+600.00K
--
May 09, 2025
Kim (Christopher)
277.50K
2.4%
+277.50K
--
May 16, 2025
é¢é£ETFî
éæå
æ¯ç
ããŒã¿ãªã
é
åœéî
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²î
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
